By targeting the activation of the PRDX5/SLC7A11‐GPX4 axis and inhibiting ferroptosis, SAB may mitigate renal tubular cell death and preserve renal function in the context of AKI. This evidence concerns the gene SH3BP5 and acute kidney injury.